715 SP 15
Generic Name: moexipril
Pill imprint 715 SP 15 has been identified as Univasc 15 mg.
Univasc is used in the treatment of diabetic kidney disease; high blood pressure; left ventricular dysfunction; heart failure; heart attack and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Univasc 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Univasc Images
- Generic Name:
- moexipril
- Imprint:
-
715
SP 15 - Strength:
- 15 mg
- Color:
- Pink
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose
magnesium oxide
crospovidone
magnesium stearate
gelatin
hydroxypropyl cellulose
hypromellose
polyethylene glycol 6000
titanium dioxide
ferric oxide red
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Schwarz Pharma
- National Drug Code (NDC):
- 00091-3715
| NDC Code | Manufacturer / Repackager |
|---|---|
| 54569-4276 | A S Medication Solutions LLC (repackager) |
| 54868-4088 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Univasc resources
Search Again
